Supplementary Tables S3-5 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

Supplementary Tables S3-5 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

<p>Transcriptome analysis</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Nicole Dressel (16918215) (author)
Altres autors:	Loreen Natusch (16918218) (author), Clara M. Munz (16918221) (author), Santiago Costas Ramon (16918224) (author), Mina N.F. Morcos (16918227) (author), Anja Loff (16918230) (author), Björn Hiller (16918233) (author), Christa Haase (16918236) (author), Livia Schulze (16918239) (author), Patrick Müller (16918242) (author), Mathias Lesche (16918245) (author), Andreas Dahl (16918248) (author), Hella Luksch (16918251) (author), Angela Rösen-Wolff (16918254) (author), Axel Roers (16918257) (author), Rayk Behrendt (14932577) (author), Alexander Gerbaulet (16918260) (author)
Publicat:	2025
Matèries:	Cancer Molecular and Cellular Biology Immuno-oncology Hematological Cancers Immunology Innate immunity Tumor immunology animal models Stem Cell Biology Hematopoiesis
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Table S2 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis
per: Nicole Dressel (16918215)
Publicat: (2025)

Supplementary file 1_Adopting orphan receptors: zebrafish Tlr4 homologs mediate responses to group IX/X transition metals.docx
per: Aaron P.D. Fox (22686512)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
per: Yu Chen (1234761)
Publicat: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
per: Andrew O. Yam (15293045)
Publicat: (2025)

Table 1_Integrative modeling of FOXO-mediated autophagy in NSCLC: linking cGAS–STING signaling to IL-6 dynamics.xlsx
per: Divya Rani (14414412)
Publicat: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
per: Hansol Lee (15054787)
Publicat: (2025)

Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
per: Wei Hong (432102)
Publicat: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
per: Jonathan M.J. Derry (16648337)
Publicat: (2025)

Filamin A KO or S2152A KI does not affect KSHV lytic reactivation.
per: Xiaojuan Li (351842)
Publicat: (2025)

Stimulating PV cells at nonsilencing levels does not improve performance of difficult visual discriminations.
per: Lilia Kukovska (22683586)
Publicat: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
per: Xuefeng Liang (3838222)
Publicat: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
per: Xuefeng Liang (3838222)
Publicat: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
per: Xuefeng Liang (3838222)
Publicat: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
per: Xuefeng Liang (3838222)
Publicat: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
per: Xuefeng Liang (3838222)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_c7ktbk3cgv32i6tufad8ca41e2